More Clinical Articles

Clinical

Epilepsy: 3D Printing provides an Easier Pill to Swallow

Dr Nicola Davies, (Nov 27, 2015)

Thomas West, Aprecia Pharmaceuticals, tells us how they are using 3D printing to revolutionize the way people take medicine.
Clinical

Future Signs: Putting Patients First

Des Sampson, (Nov 19, 2015)

With technology advancing rapidly, Medical Futurist Dr. Bertalan Meskó predicts the future facing medicine, pharma and personal healthcare.
Clinical

Point-of-Care Armory against Antimicrobial Resistance

Dr Nicola Davies, (Nov 10, 2015)

We spoke to Paul Chapman, member of the Longitude Prize advisory panel, about the Prize for a solution to antimicrobial resistance.
Clinical

Engaging Patients as Co-Creators

Dr Nicola Davies, (Oct 13, 2015)

Dr. Kalahn Taylor-Clark on translating principles of patient-centricity into specific actions.
Clinical

Introducing the Behavioral Element to Clinical Trials

Dr Nicola Davies, (Sep 29, 2015)

We explore a new trial design that takes into consideration the behavioral elements of participants - the 2 x 2 trial design.
Clinical

Personalized Medicine Ultimate Form of Patient-Centricity

Zuzanna Fimińska, (Sep 14, 2015)

Customized treatments are the final step in putting patients at the center of pharma’s operations.
Clinical

Artificial Intelligence – A Brave New World for Pharma

Dr Nicola Davies, (Sep 1, 2015)

Dr Andree Bates explains how artificial intelligence can help reduce trial time, crunch data, and facilitate healing.
Clinical

Bridging the Diversity Gap in Clinical Trials

Danielle Barron, (Aug 12, 2015)

Melva Covington on strategies to encourage the production of clinical-trial data that more accurately reflects real-world diversity.
Clinical

Medication Adherence Platforms: A New Way to Optimize Clinical Trial Outcomes

Moses Zonana, (Jul 28, 2015)

About half of new drug compounds fail to demonstrate efficacy in therapeutic trials. The root cause - low medication adherence.
Clinical

Patient-Reported Outcome Measures for Cystic Fibrosis

Dr Nicola Davies, (Jul 23, 2015)

Dr Nicola Davies explores the utility of PROMs in pharma, with a focus on cystic fibrosis.

Pages